Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery

The Journal of Thoracic and Cardiovascular Surgery - Tập 127 - Trang 414-420 - 2004
Yackov Berkun1, Amir Elami2, Karen Meir3, Dror Mevorach4, Yaakov Naparstek4
1Department of Pediatrics, Bikur Cholim Hospital, Jerusalem, Israel
2Department of Cardiothoracic Surgery, Hadassah University Hospital, Jerusalem, Israel
3Department of Pathology, Hadassah University Hospital, Jerusalem, Israel
4Department of Medicine, Hadassah University Hospital, Jerusalem, Israel

Tài liệu tham khảo

Levine, 2002, The antiphospholipid syndrome, N Engl J Med, 346, 752, 10.1056/NEJMra002974 Asherson, 1989, The “primary” antiphospholipid syndrome, Medicine (Baltimore), 68, 366, 10.1097/00005792-198911000-00004 Espinola-Zavaleta, 1999, Echocardiographic evaluation of patients with primary antiphospholipid syndrome, Am Heart J, 137, 973, 10.1016/S0002-8703(99)70424-2 Turiel, 2000, Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography, Lupus, 9, 406, 10.1191/096120300678828532 Nesher, 1997, Valvular dysfunction in antiphospholipid syndrome, Semin Arthritis Rheum, 27, 27, 10.1016/S0049-0172(97)80034-0 Alvarez-Blanco, 1994, Severe valvular heart disease in a patient with primary antiphospholipid syndrome, Lupus, 3, 433 Amital, 1999, Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome, Clin Exp Rheumatol, 17, 99 Araki, 1997, A case report on mitral valve replacement associated with antiphospholipid syndrome in systemic lupus erythematosus, Kyobu Geka, 50, 480 Hasegawa, 2001, Mitral stenosis and regurgitation with systemic lupus erythematosus and antiphospholipid antibody syndrome, Jpn J Thorac Cardiovasc Surg, 49, 711, 10.1007/BF02913510 Hogan, 2000, Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery, Mayo Clin Proc, 75, 971, 10.4065/75.9.971 Galve, 1992, Valvular heart disease in the primary antiphospholipid syndrome, Ann Intern Med, 116, 293, 10.7326/0003-4819-116-4-293 Kato, 2001, Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure, Jpn J Thorac Cardiovasc Surg, 49, 171, 10.1007/BF02913596 Matsuyama, 1999, Aortic valve replacement for aortic regurgitation in a patient with primary antiphospholipid syndrome, Jpn Circ J, 63, 725, 10.1253/jcj.63.725 Myers, 1999, Double valve replacement in a patient with anticardiolipin antibody syndrome, Perfusion, 14, 397, 10.1177/026765919901400512 Noji, 1995, Successful surgical treatment of mitral regurgitation associated with anti-phospholipid syndrome and systemic lupus erythematosus, Nippon Kyobu Geka Gakkai Zasshi, 43, 1176 Sakaguchi, 1998, Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome, Jpn J Thorac Cardiovasc Surg, 46, 257, 10.1007/BF03217739 Schumacher, 1995, Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome, Dtsch Med Wochenschr, 120, 795, 10.1055/s-2008-1055410 Erkan, 2002, Perioperative medical management of antiphospholipid syndrome, J Rheumatol, 29, 843 East, 2000, Antiphospholipid syndrome and cardiac surgery, Anesth Analg, 90, 1098, 10.1097/00000539-200005000-00017 Wilson, 1999, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome, Arthritis Rheum, 42, 1309, 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F Edmunds, 1996, Guidelines for reporting morbidity and mortality after cardiac valvular operations, Ann Thorac Surg, 62, 932, 10.1016/S0003-4975(96)00531-0 Cervera, 2000, Recent advances in antiphospholipid antibody-related valvulopathies, J Autoimmun, 15, 123, 10.1006/jaut.2000.0405 Kaplan, 1992, Cardiac manifestations of the antiphospholipid syndrome, Am Heart J, 124, 1331, 10.1016/0002-8703(92)90420-Z Hojnik, 1996, Heart valve Involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome, Circulation, 93, 1579, 10.1161/01.CIR.93.8.1579 Afek, 1999, Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome, Lupus, 8, 502, 10.1191/096120399678840873 Bulckaen, 2003, Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease, Mayo Clin Proc, 78, 294, 10.4065/78.3.294 Edwards, 2001, Prediction of operative mortality after valve replacement surgery, J Am Coll Cardiol, 37, 885, 10.1016/S0735-1097(00)01202-X Dajee, 1983, Cardiac valve replacement in systemic lupus erythematosus, J Thorac Cardiovasc Surg, 85, 718, 10.1016/S0022-5223(19)37508-7 Daugas, 2002, Antiphospholipid syndrome nephropathy in systemic lupus erythematosus, J Am Soc Nephrol, 13, 42, 10.1681/ASN.V13142 Anderson, 2000, Mild renal failure is associated with adverse outcome after cardiac valve surgery, Am J Kidney Dis, 35, 1127, 10.1016/S0272-6386(00)70050-3 Bick, 1999, Antiphospholipid-thrombosis syndromes, Haemostasis, 29, 100 Yamamoto, 2000, Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy, J Rheumatol, 27, 2035 Amigo, 2001, Prognosis in antiphospholipid syndrome, Rheum Dis Clin North Am, 27, 661, 10.1016/S0889-857X(05)70227-1